School of Medicine
Showing 11,301-11,400 of 13,104 Results
-
Ryan Taylor, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Taylor is a fellowship-trained neurologist and assistant professor in the Department of Neurology and Neurological Sciences, Memory Disorders Division. He provides patient care at the Stanford Center for Memory Disorders.
His areas of expertise include diagnosing and treating illnesses that impair thinking, memory, behavior, and speech. Dr. Taylor’s clinical focus includes Alzheimer’s disease, Lewy body disease, frontotemporal dementia, primary progressive aphasia, posterior cortical atrophy, Creutzfeldt-Jakob disease, autoimmune encephalitis and other rapidly progressive dementias. He works with patients and families to provide diagnostic clarity and individualized treatment plans.
Dr. Taylor’s academic and research interests combine clinical and scientific understandings of dementia with a philosophical inquiry into the structure of conscious experience. His original clinical research includes diverse topics, such as advances in diagnosing Creutzfeldt-Jakob disease and the clinical characterization of adult-onset hereditary dementias. Dr. Taylor has published work instrumental in identifying the potential role of fentanyl in a syndrome of sudden onset amnesia that emerged during the opioid crisis.
He has presented research at the American Academy of Neurology and published in peer-reviewed journals, including the Canadian Journal of Neurological Sciences and Methods in Molecular Biology. He has also published a chapter on the diagnosis and treatment of frontotemporal dementia and was a reviewer for Neurocase.
Dr. Taylor is a fellow of the Royal College of Physicians of Canada. He has taught residents and medical students clinical skills, neuroanatomy, neuro-imaging, and other subjects. He also has delivered Grand Rounds presentations on dementia, epilepsy, and pediatric neurology. -
David Tehrani, MD, MS
Affiliate,
BioDr. Tehrani is a board-certified, fellowship-trained interventional cardiologist with Stanford Health Care Tri-Valley in the East Bay.
He is focused on building long-term relationships with his patients and their families, while sharing his evidence-based expertise in the noninvasive and minimally invasive management of cardiovascular disease. He takes pride in forming care plans based on mutual decision-making.
Dr. Tehrani’s research interests include cutting-edge technology and advancements in medical management of cardiovascular disease. His clinical research studies and funded clinical research trials have focused on cardiovascular biomarkers, coronary physiology, cardiac hemodynamics, cardio-oncology, and procedural closure devices. His research background has been instrumental in helping him provide individualized, evidence-based care plans for conditions ranging from advanced heart failure to complex coronary disease.
Dr. Tehrani has an extensive clinical research background, with over 40 peer-reviewed publications in top cardiology journals. He has done over 30 presentations at conferences, including the American Heart Association (AHA) and American College of Cardiology (ACC) national meetings.
Dr. Tehrani is a member the American College of Cardiology, the American College of Physicians, the American Heart Association, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. -
Nicholas Telischak, MD, MS
Clinical Associate Professor, Radiology
Clinical Associate Professor (By courtesy), NeurosurgeryBioA native of the Bay Area, Dr. Nick Telischak is a dual fellowship-trained neurointerventional surgeon and neuroradiologist at Stanford Health Care. With board certifications in radiology and neuroradiology, he serves as a clinical associate professor in the Department of Radiology, and, by courtesy of the Department of Neurosurgery, at Stanford School of Medicine.
Dr. Telischak specializes in diagnosing and treating artery disorders in the brain and spine, including brain aneurysms, arteriovenous malformations (AVM), and dural arteriovenous fistula (dAVF), and stroke. Dr. Telischak also specializes in venous disorders in the brain including idiopathic intracranial hypertension (IIH). He also has a special interest in pulsatile tinnitus, a whooshing sound in the ears that occurs in rhythm with the heartbeat. Dr. Telischak also treats painful spinal (vertebral) fractures, spinal metastases (tumors resulting from cancer elsewhere in the body), and congenital vascular malformations (blood vessel abnormalities that are present at birth). He treats these conditions using minimally invasive, image-guided procedures and state-of-the-art technology.
Prior to joining Stanford Health Care, Dr. Telischak helped develop the Stroke Program at California Pacific Medical Center and Mills-Peninsula Medical Center, giving him a broad perspective on medical care systems within the Bay Area.
Dr. Telischak’s research focuses on:
• Identifying biomarkers to diagnose large vessel occlusion stroke (stroke in one of the large arteries in the brain)
• Noninvasive MRI techniques for diagnosing idiopathic intracranial hypertension (high pressure within the skull)
He is also the principal investigator for a study examining the efficacy of vertebroplasty and kyphoplasty for the treatment of painful vertebral compression fractures.
In addition, Dr. Telischak holds a master’s degree in bioengineering. He has worked with several companies pioneering new devices to treat brain aneurysms, vascular malformations, and strokes caused by blood clots, as well as new treatments for venous disorders in the brain caused by idiopathic intracranial hypertension.
Dr. Telischak has published more than 20 peer-reviewed articles and has been invited to present locally, nationally, and internationally at meetings for the Society of NeuroInterventional Surgery, American Society of Neuroradiology, and Jornada de Stroke in Asuncion, Paraguay, where he has served as visiting faculty. -
Melinda L. Telli, M.D.
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMy research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents.
-
Joyce Teng, MD, PhD
Professor of Dermatology and, by courtesy, of Pediatrics
BioJoyce Teng, MD, PhD is a professor in dermatology at Stanford University. She is affiliated with multiple hospitals in the area, including Lucile Salter Packard Children's Hospital (LPCH) at Stanford and Stanford Hospital and Clinics (SHC). She received her medical degree from Vanderbilt University School of Medicine and has been in practice for more than 12 years. She is one of the 6 pediatric dermatologists practicing at LPCH and one of 72 at SHC who specialize in Dermatology. She sees patients with rare genetic disorders, birthmarks, vascular anomalies and a variety of inflammatory skin diseases. She is also an experienced pediatric dermatological surgeon. Her research interests are drug discovery and novel therapy for skin disorders.
-
Nelson Teng
Professor of Obstetrics and Gynecology (Oncology), Emeritus
Current Research and Scholarly InterestsGynecologic Malignancies
Immunotherapy
Biologic Response Modifiers
New Drug Development
Antigenic specificities of human antibodies encoded by the VH4-34 gene -
Valerie Teng
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Valerie Teng is a board certified family physician with special interests in preventative medicine and women's health. Her experiences in caring for patients with chronic conditions, such as diabetes and hypertension, have fueled her desire to partner with patients to enter healthier lifestyles. She is also passionate about providing comprehensive care to patients of all ages, including newborns and teens.
During her residency training, Dr. Teng explored many opportunities in medical education through the O’Connor-Stanford Leaders in Education Residency (OSLER) program. She is delighted to continue in medical education as a part of the faculty at Stanford Family Medicine. -
Azusa Terasaki
Postdoctoral Scholar, Pathology
BioAzusa Terasaki, MD, PhD, is a Postdoctoral scholar in the Department of Pathology at Stanford University School of Medicine. Her research focuses on tumor immunology and cancer metabolism, with a particular interest in mitochondrial transfer between cancer and immune cells and its role in immune suppression and metastasis.
Dr. Terasaki received her medical degree and PhD in Japan, where she completed her surgical training and is a board-certified surgeon with additional certifications as a breast specialist and in cancer therapy. During her clinical career, she developed a strong interest in translational research that bridges fundamental discoveries and patient care.
Her current work investigates how cancer cells reprogram immune cells through organelle transfer, integrating imaging, flow cytometry, and multi-omic approaches to uncover novel mechanisms of tumor–immune interaction. Her goal is to identify new therapeutic targets and biomarkers to improve cancer treatment outcomes. -
Stefano Testa
Instructor, Medicine - Oncology
BioDr. Testa is a medical oncologist and physician-scientist specializing in cellular therapy and the care of patients with soft tissue and bone sarcomas. He earned his medical degree from the University of Naples Federico II in Naples, Italy. He subsequently moved to the United States and conducted research in the laboratory of Dr. Ronald Levy at Stanford University, where he studied intratumoral vaccination strategies and mRNA delivery platforms designed to target B cells and T cells in vivo. He completed his internal medicine residency at Stanford University, followed by a fellowship in hematology and oncology at Beth Israel Deaconess Medical Center. Dr. Testa’s research focuses on identifying targets for adoptive T-cell therapies in solid tumors, particularly soft tissue and bone sarcomas, and on novel synthetic biology approaches to enhance the effectiveness of T-cell therapies against solid tumors.
-
Jeffrey Teuteberg
Professor of Medicine (Cardiovascular Medicine)
BioHe is currently a Professor of Medicine at Stanford, but is no longer seeing patients as he is on leave and working with industry.
His research interests are in clinical outcomes in patients after transplant and mechanical support as well as novel approaches to immunosuppression. He has participated in many single-center and multi-institutional research studies and has published widely in the fields of transplant and mechanical support. He served as President of the International Society of Heart and Lung Transplantation in 2018. -
Winifred Teuteberg
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Teuteberg completed residency training in Internal Medicine at the University of Chicago and a Palliative Medicine Fellowship at Massachusetts General Hospital. She joined the faculty at Stanford in 2017 and currently sees patients as a part of the inpatient palliative care consult team at Stanford Healthcare.
She has been the clinical director or Stanford Medicine's implementation of the Ariadne Labs' Serious Illness Care Program since its inception in 2018. Her interests include communication skills training, leveraging predictive algorithms to identify patients who would most benefit from serious illness conversations, how to empower non-physician clinical team members to participate in this work, and best practice for EHR builds related to advance care planning. -
Haluk Tezcan, MD
Adjunct Clinical Associate Professor, Medicine - Oncology
BioClinical focus:
Breast Oncology
Molecular Diagnostics
Dr. Tezcan is a medical oncologist and hematologist with over three decades of diverse experience in cancer management and research.
He is leading the clinical development of Droplet Biosciences' novel liquid biopsy technology, a first-in-class lymphatic fluid molecular residual disease assessment, overseeing the scientific and clinical development of the technology. With over three decades of direct patient care and clinical trial experience as a principal investigator and director, both in academia and private practice, he has a firsthand understanding of the unmet clinical needs of physicians and patients, as well as broad experience in clinical trial design and implementation.
He is also co-principal at Athea Oncology, guiding practices and hospitals in developing clinical trial programs and high-value real-world data collection and diagnostic companies in clinical development. He is also a reviewer of JCO Precision Medicine.
Before joining Athea Oncology and Droplet Biosciences, he was the co-founder of LexentBio, which was successfully acquired by Roche/FMI. He also served as Director of Translational Medicine at Genomic Health and as Vice President, leading oncology development at Counsyl, where he integrated science with clinical product development. He established the CA.RE.foundation, a cancer research foundation dedicated to enabling the execution of clinical trials across community oncology sites throughout the Northwest US. He has independently built multiple software tools to help oncologists navigate the practical realities of their daily work. -
Sonoo Thadaney Israni
Executive Director, Presence + Program in Bedside Medicine, Med/Program/Bedside Med
Current Role at StanfordExecutive Director, Presence (med.stanford.edu/presence.html) & Program in Bedside Medicine/Stanford 25 (stanfordmedicine25.stanford.edu)
Instructor Stanford University School of Medicine - Authentic Courage for Constructive Change: Skills and Practice for Leadership
LinkedIn Profile: www.linkedin.com/in/sonoo/ -
Julie Ngoc Thai, MD, MPH
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Thai is a fellowship-trained specialist in geriatric medicine. She provides care at the Stanford Senior Care Clinic.
She completed her fellowship training at the University of California, San Francisco. She is board-certified in family medicine through the American Board of Family Medicine .
Dr. Thai earned her medical degree from Michigan State University College of Human Medicine. She completed her residency in family medicine at McLaren Flint/Michigan State University College of Human Medicine where she served as chief resident.
She also holds a Master of Public Health degree from Columbia University.
Dr. Thai has a background in clinical and population health research. She recently received a grant from the Blue Cross Blue Shield of Michigan Foundation to study the role of motivational interviewing in smoking cessation.
She contributed to research in rheumatoid arthritis, lupus, and ankylosing spondylitis in the Division of Rheumatology, Department of Medicine at Cedars Sinai Medical Center.
Dr. Thai was also an endourology research fellow in the Department of Urology at Mount Sinai Health System. Research focused on renal stone disease, clinical markers and outcomes, and testing and development of new technologies.
She has co-authored articles on topics such as caregivers’ communication with elders living with late-life disability, palliative care practices in diverse settings, and the social consequences of forgetfulness and Alzheimer’s disease. These articles appeared in the American Journal of Hospice and Palliative Medicine, Journal of Palliative Medicine, Journal of Mental Health Aging, and other peer-reviewed journals
Dr. Thai is a member of the American Geriatrics Society, American Academy of Family Physicians, and California Academy of Family Physicians. She is also an inductee of the Alpha Omega Alpha Honor Medical Society.
She has volunteered with homeless shelters, women’s advocacy groups, Goodwill, the American Red Cross, and AmeriCorps.
Dr. Thai is fluent in English and proficient in speaking Vietnamese. -
Christoph Thaiss
Associate Professor of Pathology
Current Research and Scholarly InterestsThe Thaiss Lab investigates how gut-brain interactions influence health and disease. By studying microbiome-host communication, the lab explores how microbial signals impact immune function, metabolism, and neurological health. Using multi-omic technologies and computational models, they aim to uncover mechanisms underlying inflammation, neurological disorders, and metabolic diseases. Their research supports the development of personalized therapies targeting the gut-brain axis.
-
Avnesh Thakor
Professor of Radiology (Pediatric Radiology)
Current Research and Scholarly InterestsInterventional Radiologists can access almost any part of the human body without the need for conventional open surgical techniques. As such, they are poised to change the way patients can be treated, given they can locally deliver drug, gene, cell and cell-free therapies directly to affected organs using image-guided endovascular, percutaneous, endoluminal, and even using device implantation approaches
-
Simon Thalén
Postdoctoral Scholar, Radiological Sciences Laboratory
BioI am a clinical physiology resident at Karolinska University Hospital and completed my thesis on cardiovascular magnetic resonance imaging (MRI). With a background in mathematics, I am trying to live at the intersection of mathematics, technology, and medicine. My thesis focused on MRI evaluation of constrictive heart diseases, such as pericardial effusion and constrictive pericarditis. I used phase contrast MRI to measure respiratory variation in mitral and tricuspid peak early blood flow velocities and T1 mapping to characterize pericardial effusion fluid.
-
Tristan Tham, MD
Assistant Professor of Otolaryngology - Head & Neck Surgery
BioDr. Tristan Tham is an Ear, Nose, and Throat (ENT) surgeon and Assistant Professor in the Department of Otolaryngology – Head & Neck Surgery at Stanford University School of Medicine.
Born and raised in Singapore, Dr. Tham earned his medical degree with honors from the Royal College of Surgeons, where he received the Norman Rae Gold Medal for academic excellence and thesis award. Following medical school, he began his career as a junior doctor at Singapore General Hospital, where he was honored with the ‘Heart of Gold’ Award for achieving the highest patient satisfaction ratings. He then pursued further research training at the New York Head & Neck Institute, where he was eventually promoted to Director of Patient-Oriented Research.
Dr. Tham completed his ENT surgery residency in New York City at the Manhattan Eye, Ear & Throat Hospital, Lenox Hill Hospital, and Long Island Jewish Medical Center. During his residency, he was selected for membership in the Alpha Omega Alpha Honor Medical Society.
As an ENT surgeon, Dr. Tham treats a wide range of head and neck disorders, including sinus issues and obstructive sleep apnea, cancers of the sinus cavity and salivary glands, thyroid and parathyroid disorders, head and neck tumors, and chronic ear conditions. He prioritizes a personalized approach to care, working closely with patients to develop individualized treatment plans that address their unique needs.
Dr. Tham's contributions to the medical field extend beyond his clinical practice. He has authored over 200 publications, abstracts, and presentations. He has also served as Associate Editor for Otolaryngology – Head & Neck Surgery, the official journal of the American Academy of Otolaryngology.
Beyond his work in the clinic, Dr. Tham is committed to giving back through pro bono efforts in underserved regions around the world. He has participated in multiple medical missions abroad, reflecting his dedication to making a difference beyond his practice.
When he's not at work, Dr. Tham enjoys reading, weightlifting, and exploring the beautiful nature of Northern California with his wife and children. -
Swaraj Thaman
Life Science Research Professional, Pediatrics - Endocrinology
Current Role at StanfordLife Science Research Professional 1, Translational Genomics of Diabetes Laboratory, Department of Pediatrics - Endocrinology, School of Medicine
-
Suzanne Tharin
Associate Professor of Neurosurgery
Current Research and Scholarly InterestsThe long-term goal of my research is the repair of damaged corticospinal circuitry. Therapeutic regeneration strategies will be informed by an understanding both of corticospinal motor neuron (CSMN) development and of events occurring in CSMN in the setting of spinal cord injury. MicroRNAs are small, non-coding RNAs that regulate the expression of “suites” of genes. The work in my lab seeks to identify microRNA controls over CSMN development and over the CSMN response to spinal cord injury.
-
Kate Therkelsen, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Therkelsen is a board-certified, fellowship-trained neuro-oncologist with the Stanford Medicine Cancer Center and a clinical assistant professor in the Department of Neurology and Neurological Sciences.
She diagnoses and treats a wide range of conditions including primary brain tumors and cancers of the central nervous system, metastatic disease to the brain and spinal cord, and neurologic complications of cancer. She prepares a personalized, comprehensive care plan for each patient she serves.
Dr. Therkelsen’s research interests include clinical trials of new therapeutics, as well as ways to reduce toxicities that some patients may experience when receiving cancer treatment. Her fellowship research projects included a study of survival and long-term function among patients treated for primary central nervous system lymphoma. She also received a pre-doctoral National Institutes of Health Intramural Research Training Award for her work with the Framingham Heart Study.
She has published in Current Treatment Options in Oncology and other peer-reviewed journals. She has presented to her peers at international, national, and regional meetings, including the annual meetings of the Society of Neuro-Oncology and of the American Academy of Neurology.
Dr. Therkelsen is a member of the Society of Neuro-Oncology and the American Academy of Neurology. -
Hawa Racine Thiam
Assistant Professor of Bioengineering and of Microbiology and Immunology
Current Research and Scholarly InterestsOur current work has two branches. Branch #1 is building a quantitative and predictive understanding of how neutrophils initiate and complete NETosis. Branch #2 is identifying the molecular and biophysical mechanisms that regulate high deformability in neutrophils. These branches converge onto understanding and harnessing the impact of nuclear biophysics on immune cell functions to re-engineer neutrophils for improved health.
-
Imran Thobani
Postdoctoral Scholar, Ophthalmology
BioDr. Imran Thobani is a postdoctoral scholar in Ophthalmology co-advised by Dan Yamins and Andreas Tolias as part of the Enigma project. He is interested in building large-scale predictive models of the brain that he thinks will be useful for both scientific insights and downstream biomedical applications. He did his PhD at Stanford, where he was trained in both philosophy of neuroscience and computational neuroscience, applying this training to develop better methods for comparing artificial neural network models to the brain.
-
Amy Thomas
Visual Designer, Rad/Radiology Finance and Administration
BioI'm a passionate designer with 19 years of experience in interface, print, and web design. I love to make things look, work, and act more efficiently. Some might call it compulsion...I like to call it passion. My mind and heart are always open to challenging design problems. I thrive on finding innovative solutions to complex situations.
I started my professional career as a Visual Designer at IBM for the Storage Systems Group. My work at IBM involved close interaction with our user experience designers. The team I was on developed a software interface to help facilitate storage administrators in monitoring their storage subsystems. We created an interface that allowed the admin to see storage system status at a glance using a drill down table as well as custom built icons. The work our team completed earned several US Patents.
In March 2008, I began my career at Stanford University School of Medicine. I started as a Temporary Visual Arts Specialist. In November 2010 I was hired on full time as the Web & Graphic Designer for the Department of Radiology. My work at Stanford is very gratifying. I never expected, as an artist, to have my work matter in a way that could help other people. With each new project, I am (in a small way) contributing to the research and development of new and innovative treatments for many of the most damaging diseases. My art helps the great minds of our department explain their thinking, their research, and their findings to others in their field. -
Hannah Thomas
Ph.D. Student in Health Policy, admitted Autumn 2024
BioI am a resident in urologic surgery at the University of Toronto, currently pursuing my PhD in Health Policy (Decision Sciences) at Stanford University as a Knight-Hennessy Scholar. I previously completed a Masters in Global Health Sciences from UCSF.
I am passionate about leveraging data to guide evidence-based health policy, both domestically and globally. My doctoral thesis uses mathematical modelling to address critical disparities between the burden of disease and the urologic workforce- seeking to provide actionable insights for workforce planning and development in resource-constrained healthcare systems.
I serve on the Board of Trustees for the International Student Surgical Network. -
Lindsay Thomas, RN, MS, CNS
Affiliate, Medicine - Med/Cardiovascular Medicine
BioMs. Lindsay Thomas earned her BA in Integrative Biology from UC Berkeley in 2003 and her RN and MS from UCSF in 2006 and 2009 respectively. She completed a Double Master’s in Cardiovascular Nursing and Genomics and is a board certified clinical nurse specialist in critical care nursing. She joined the Stanford Interventional Cardiology Team in 2011 where she has pioneered the advanced practice nursing role in the cath lab and been a leader in the development of the Left Atrial Appendage Closure program. She serves as adjunct faculty for the UCSF graduate nursing program and is the co-chair of the Northern California Chapter of the Preventative Cardiovascular Nurses Association. Lindsay specializes in treating and caring for patients with established coronary artery disease and cardiovascular risk factors; she strives to provide excellent patient care and education to optimize a heart healthy life style to promote wellness with use of medications and invasive procedures when life style alone is not enough to achieve desired results. When not working Lindsay is an outdoor and exercise enthusiast, who enjoys participating in various endurance activities and has completed several triathlons. She also enjoys reading and discussions with her book club, going to the theater, and spending quality time with her friends and family.
-
Reena Thomas, MD PhD
Clinical Professor, Adult Neurology
Clinical Professor (By courtesy), NeurosurgeryCurrent Research and Scholarly Interests-Neuro Oncology Immunotherapy
-Medical Education -
Tainayah Whitney Thomas
Assistant Professor of Epidemiology and Population Health (Epidemiology)
BioTainayah Thomas, PhD, MPH is an Assistant Professor in the Department of Epidemiology and Population Health. Her research focuses on primary care improvement and diabetes prevention and management among racially and ethnically diverse populations. Dr. Thomas's research seeks to leverage delivery science research methodology to promote the integration of evidence-based research into clinical practice. Dr. Thomas is dedicated to transforming research into action by engaging community, health system, and policy stakeholders in adapting, implementing, and sustaining interventions that address health disparities and promote health equity.
-
Allison L. Thompson, Ph.D.
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Allison Thompson specializes in the treatment of Post-Traumatic Stress Disorder, anxiety and depression, and severe mental illness. She has practiced at Stanford since 2008. She has a special interest in the treatment of underrepresented and underserved populations, such as people of color.
-
Candice N. Thompson, MD, MSc, FACS
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Thompson is a board-certified general surgeon and fellowship-trained breast surgical oncology. She is a clinical assistant professor of surgery at Stanford University School of Medicine and the Medical Director for the Office of Cancer Health Equity. She is also a fellow of the American College of Surgeons.
Dr. Thompson clinical interests include treatment of women and men who have breast cancer, benign breast disease, genetic mutations, family history of breast cancer, or other breast cancer risk factors. Procedures performed by Dr. Thompson include lumpectomies (partial mastectomies) using oncoplastic techniques and hidden scar methods, skin- and nipple-sparing mastectomies, simple mastectomies with aesthetically flat closure, oncoplastic procedures, benign breast lesion excisions, axillary node dissections, and sentinel lymph node biopsies.
She completed a breast surgical oncology fellowship at Stanford University under the mentorship of one of the world’s foremost experts in the field. She completed her general surgery training at Georgetown University, where she was the co-administrative chief resident. She is passionate about equitable care and addressing healthcare disparities, especially in breast cancer.
Dr. Thompson works closely with medical oncology, radiation oncology, plastic surgery, genetics, and other breast cancer specialists in a multidisciplinary setting to provide high quality, evidence-based, and individualized care. Dr. Thompson is a strong advocate for patient education and empowerment and strives to deliver compassionate care to patients and their families.
Her research has focused on Nipple Sparing Mastectomies, Community Engagement for Breast Cancer in the Black Community, Immune responses during breast cancer treatment, and prognostic role of Circulating Tumor DNA (ctDNA) in the management of breast cancer. She also has strong research interests in community engagement, health disparities, oncoplastic surgical options, and cancer biomarkers. She has delivered presentations on a wide range of topics related to breast cancer at national and regional meetings including NRG Oncology, ASBrS, ASC.
For her scholarship and research achievements, Dr. Thompson has won numerous honors and awards. She has earned the resident teaching award during her chief year at Georgetown. She was awarded the Stanford Cancer Institute Clinical Innovation Fund Grant for her work in educating the Black Community about Breast Health and Breast Cancer (2022). She was also awarded the prestigious NCI Early-Surgeon Scientist Program (ESSP) Award to support her early career as a surgeon scientist(2024). She also serves on the AAS Academic Advancement Committee, NRG Oncology Surgical Oncology Committee, NCCN Breast Screening and Diagnosis Panel, and TOUCH Black Breast Advisor for Pink Table Talk.
Dr. Thompson is a member of the American College of Surgeons (ACS), American Society of Breast Surgeons (ASBrS), Society of Surgical Oncology (SSO), Society of Black Academic Surgeons (SBAS), Association of Women Surgeons (AWS), National Comprehensive Cancer Network® (NCCN®), and American Medical Association (AMA).
Outside of work, Dr. Thompson enjoys pilates, tennis, baking, sewing, wine tasting, and traveling. -
Dolores Gallagher Thompson, PhD, ABPP
Professor (Research) of Psychiatry and Behavioral Science (Public Mental Health and Population Sciences), Emerita
Current Research and Scholarly InterestsMy current research focuses on use of technology to improve mental health of older persons and their family members. I have a strong interest in how cultural diversity impacts mental health access, services, and outcomes. I am currently involved in several international research and demonstration projects in collaboration with the World Health Organization and the health care system in Thailand as well as projects in the US - notably, with rural caregivers and those of Asian American ancestry.
-
John W. Thompson
Clinical Instructor, Adult Neurology
BioDr. Thompson is a physician-scientist and Clinical Instructor in the Division of Comprehensive Neurology at Stanford University School of Medicine. He cares for adults across the full range of neurologic conditions. Deeply aware of how these conditions can reshape a person’s life, he is committed to partnering with patients and their families to navigate diagnostic and treatment challenges. He has a particular interest in caring for patients with complex medical comorbidities and those transitioning from inpatient to outpatient settings. His other areas of focus include neuroimmunology and the prevention of chronic neurologic diseases such as stroke and dementia.
Dr. Thompson earned his medical degree from the David Geffen School of Medicine at UCLA as part of the UCLA-Caltech Medical Scientist Training Program, where he received the Richard D. Walter Award for Excellence in Neurology. He completed his PhD in Cellular and Molecular Neurobiology at the California Institute of Technology, studying how protein glycosylation affects neuronal signaling and metabolism. He went on to complete his neurology residency at UCLA, where he designed computational methods to resolve dementia subtypes in an unbiased manner. At Stanford, his research focuses on the development of novel multiomics technologies to understand the genetic and molecular underpinnings of frontotemporal dementia and other neurodegenerative disorders. Beyond the clinic and the laboratory, Dr. Thompson is a passionate educator dedicated to mentoring medical students and residents. Across all his work, his overarching goal is to help patients better understand and confront neurologic disease through the translation of high-dimensional data into meaningful clinical insights. -
Larry W. Thompson, Ph.D.
Professor (Research) of Medicine (Endocrinology, Gerontology, and Metabolism), Emeritus
Current Research and Scholarly InterestsDr. Thompsons interests include psychosocial treatments for individuals with bipolar disorder and /or other serious mental illnesses; cognitive/behavioral therapy for late-life depression; intervention research with culturally diverse individuals with depression; and psychophysiological research on stress & coping.
